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10.1    Introduction  
 
The introduction of the Gram stain over a century ago into Clinical Microbiology has been 
profound and enduring (Gram, 1884). The test, based on the cell’s colour reaction to the 
stain, enabled the dichotomous division of the microbiological kingdom and stimulated 
microbiologists to seek new methods to further characterise potential pathogens. Today, even 
in the current era of whole genome sequencing (WGS), many traditional diagnostic 
laboratories such as those long-established in Public Health England, UK are designated as 
enteric ‘Gram- negative’ or ‘Gram positive’ food pathogens to describe their function. As 
new physiological tests and subsequently chemotaxonomic methods were introduced into 
microbiology, various editions of Bergey’s Manual of Determinative Bacteriology (from 
1923 to 1974), assigned chapters/volumes of different taxa in accord with their reaction to the 
Gram stain. There was a brief period when peptidoglycan patterns, based mainly upon the 
characteristic dibasic amino acids lysine or diaminopimelic acid were considered as a new, 
well defined dichotomous key for the microbial kingdom (Schleifer and Kandler,1972). 
However, while this was retained as a key character for the description of bacterial species, 
various anomalies within some genera such as the Bacteroides or Fusobacterium prevented 
this from being universally adopted.  
Microbiology changed fundamentally with the introduction by Sneath (1957) of 
numerical phenetic analysis which strongly advocated a transition from single weighted tests 
to multiple based characters to delineate nomenclatural groups. The arrival of DNA/DNA 
reassociation and subsequently16S rRNA re-enforced a move towards a phylogenetic-based 
structure and added rigor to the definition of a species. Thus, as microbiology progressed 
from an arbitrary identification system to one based upon systematic classification principles, 
new characters were reported and microbial cellular components were analysed for the first 
time to maintain a polyphasic approach (see Goodfellow and Board, 1980; Goodfellow and 
Minnikin, 1985, Minnikin and Goodfellow,1980). During this process, mass spectrometry 
was used for the first time for microbial systematics. Both polar and particularly non-polar 
lipids revealed enormous complexity and diversity and exhibited good congruence with 
established taxonomic methods. Very multifaceted, hitherto, poorly defined groups such as 
the “Acid-Fast” bacteria that encompassed several ill-defined taxa such as Mycobacterium, 
Nocardia, Actinomadura, Corynebacterium, Rhodococccus  and others began to show 
resolution.  Such data provided the impetus to drastically transform microbiology from a 
‘determinative’ to a ‘systematic’ based approach and for the first time Bergey’s Manuel 
reflected this change to Bergey’s Manual of Systematic Bacteriology (1984) and microbial 
classification was no longer pivotally structured around the Gram stain (Shah and Gharbia, 
2011).  
 
10.2    Proteins in microbial systematics 
The use of proteins profiles in microbial systematics has long been regarded as highly 
compatible with phylogenetic approaches since proteins were envisioned as a direct product 
of the genome. Numerous studies were reported that showed excellent correlation between 
protein profiles and methods such as DNA/DNA reassociation (see review Jackman, 1985). 
The immense complexity of the bacterial proteome was already established through studies 
of intermediary metabolism and microbial biochemistry. However, although protein 
sequences were being reported as early as 1967 (Ambler, 1967) and its immense value in 
microbial systematics demonstrated (Ambler, 1985), existing technologies were considerably 
laborious, costly and outside the scope of bacterial systematics. Microbiologists therefore 
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turned towards electrophoretic-based platforms to provide insight into the expressed 
proteome of bacterial species. Three basic approaches were pursued viz. multilocus enzyme 
electrophoresis (MLEE, Selander et. al., 1986), peptide/protein profiles using sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis ([SDS-PAGE, Laemmli, 1970) and isoelectric 
focusing protein profiling (IEF-PP) (eg. Shah et al., 1982).  When analyses commenced, 
optimisation of methods to release cellular proteins were based largely upon the Gram stain 
but this was due to differences in complexity of the cell envelope rather than taxonomic 
rationale. Early results revealed enormous implications for bacterial systematics and soon 
methods such as multilocus enzyme electrophoresis (MLEE), based upon the electrophoretic 
mobility of specific enzymes (see eg. Selander et. al., 1986) became established as a tool for 
microbial systematics. This subsequently translated into its high-resolution counterpart, 
Multilocus Sequence Typing (MLST), based upon comparative DNA sequencing of the 
selected gene. MLST is used widely today for systematics, evolution and epidemiology (see 
eg. High et al., 2015). However, both SDS-PAGE and IEF-PP continued to have a significant 
impact in microbial identification and phylogeny. In an early study, strains designated 
Bacteroides oralis were shown to exhibit such profound heterogeneity using IEF-PP that it 
led to the proposal of three new species (Shah and Collins 1981, Shah et al., 1982). Results 
corroborated with other chemotaxonomic methods and subsequently by comparative 16S 
rRNA sequencing (Shah and Collins, 1981). SDS-PAGE is robust, inexpensive, simple and 
rapid and is still used in its original form today by some laboratories (see eg. Berber, 2004). 
 
10.3    Arrival of MALDI-TOF MS in Microbiology 
 
A major drawback of the above electrophoretic methods is that they rely solely on pattern-
matching algorithms and provide no information on the protein biomarkers that were used to 
differentiate taxa. In theory new forms of mass spectrometry (MS) such as MALDI-TOF MS 
and Tandem MS/MS should have provided the analytical tools to develop these methods, 
analogous to that achieved for transforming MLEE to MLST. However, systematic analysis 
using whole cell proteins profiles are only now gaining momentum as new forms of mass 
spectrometry become more accessible. Current MS enable identification of post-translational 
modification of proteins that cannot be deduced from WGS and is likely to gain widespread 
application both is cell biology and systematics as these techniques become automated, 
accessible, miniaturised, portable and less costly.  
The platform that paved the way for these developments is Matrix-Assisted Laser 
Desorption/Ionisation Time of Flight Mass Spectrometry (MALDI-TOF MS). Earlier forms 
of mass spectrometry that were used in microbiology such as electron impact or pyrolysis 
mass spectrometry had upper detection limits of ca.1,500 daltons and were therefore 
restricted to small molecules such as lipids and metabolites (Goodfellow and Minnikin, 
1985). Proteins are orders of magnitude greater and initial success was reported in the 
analysis of small proteins using Fast Atom Bombardment Mass Spectrometry in the mid-
1990s (see eg Drucker, 1997) but this soon gave way to the more efficient and versatile 
platform, MALDI-TOF MS which prominent microbiologists have described as 
‘transformational’.  
Pioneered by the late Franz Hillenkamp’s group in the mid-1980s (Karas, Bachmann 
and Hillenkamp, 1985; Karas et al., 1987), MALDI-TOF MS soon became established as a 
method for analysis of high molecular weight compounds, particularly proteins (Karas and 
Hillenkamp, 1988;Tanaka et. al.,1988). The work of Cain, Lubman and Weber (1994) drew 
attention to its first application in microbiology through their publication, “Differentiation of 
bacteria using protein profiles from matrix assisted laser desorption/ionization time-of-flight 
mass spectrometry”. The response by the Mass Spectrometry company, Kratos Analytical, 
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was to launch the first ‘bench-top’ MS instrument that was ground breaking for this early 
period. Almost simultaneously, three papers reported its use 1996, (Claydon et. al.,1996; 
Holland et. al.,1996 and Krishnamurthy and Ross, 1996) and provided further evidence of its 
potential. The response by microbiologists was inconsequential perhaps due to the work 
being reported in non-microbiological journals and possibly more significant, the previous 
failure of MS methods such as Pyrolysis MS (see eg Shute et. al.,1985) to gain acceptance as 
a tool for bacterial systematics.   
  
10.4    Establishing MALDI-TOF MS in clinical Microbiology  
In mid-1997, Public Health England (then Public Health Laboratory Service and later Health 
Protection Agency) established a new laboratory (Molecular Identification Services Unit, 
MISU) to identify novel, emerging and atypical pathogens that were increasingly being 
reported in the UK. This provided an opportune moment to access the potential of new and 
emerging technologies and the various MALDI-TOF MS platforms were among those 
introduced with almost immediate impact for MISU. The laboratory was in the midst of 
assembling a database of MALDI-TOF MS that included most staphylococcal species. A 
sample labelled “atypical Staphylococcus aureus” was received by MISU for identification.  
Its MALDI-TOF MS spectrum was shown to be incompatible with any staphylococci and the 
isolate was identified by 16S rRNA as Exiguobacterium aurantiacum. The inclusion of 
spectral data into the database facilitated the subsequent rapid identification of 18 blood 
cultures using the Kratos Linear MALDI-TOF MS and allowed notification to be sent to 
hospitals to alert them of impending threat. The clinical application of MALDI-TOF MS 
increased substantially and early reviews reflected its increasing optimism (see eg Belén et 
al., 2019; Singhal et al., 2015). It was already hailed as “the quantum leap” by Greub (2010) 
and later regarded as the gold standard for clinical microbiology (Schubert and Kostrzewa 
(2017). However, the clinical applications of MALDI-TOF MS, which was accredited and 
widely used in Europe, only gained widespread success in North America when quality 
assurance procedures were subsequently established (Bourassa, 2018) and FDA approval 
received.  
From 1998, 21 consecutive international conferences were held at PHE and 
subsequently with Middlesex University, London to advance the application of these 
technologies in microbiology (see Shah and Gharbia, 2017). Among the early MALDI-TOF 
MS methods was the novel application of DNA resequencing that was developed by 
Sequenom GmbH Hamburg. The system designated MassARRAY single‐nucleotide 
polymorphism (SNP) typing platform employed a MALDI‐TOF MS coupled with single‐
base extension PCR for high‐throughput multiplex SNP detection (see review, Honisch, Chen 
and Hillenkamp, 2010). Very complex traditional serotyping methods such as the 
Kauffmann-White for the rapid typing of Salmonella were shown to be amenable for transfer 
to the Sequenom MALDI-MS platform (Bishop, Arnold, and Gharbia, 2010; Syrmis et. al., 
2011). However, despite its huge potential for microbial analysis, the technology never 
gained traction in Microbiology although it continued to find applications in clinical 
diagnostics and is currently used for detection of cancer biomarkers (see eg Gloss et. al., 
2012).  Subsequently, PCR based products were analysed using tandem MS/MS which was 
excellent for species identification and typing but perhaps because of its colossal cost, the 
system, designated PCR-ESI-MS, was not acquired by laboratories and soon became obsolete 
(see review, Emonet et. al., 2010).  
Protein-based target molecules were viewed with more optimism by microbiologists 
and different approaches were explored. While the standard MALDI instrument developed by 
Kratos Analytical Ltd employed a stainless target plate for sample analysis, the Ciphergen 
Biosystems instrument utilised a chemically active surface (ProteinChip Array) to selectively 
 5
capture various classes of proteins (Figure 10.1). Thus, the same sample, using sinapinic acid 
as its matrix solution, could be analysed by using various ProteinChips to obtain more in-
depth coverage of the proteome (Shah et al., 2010).  
 
   [Insert Figure 10.1. MALDI-TOF MS profiles obtained for the same sample using three 
different ProteinChip arrays (NP1, SAX2 and WCX1) to reveal the complexity of a sample. 
To enable rapid visual comparison of spectra, the software converted the mass ions into a Gel 
view images; the greater the mass intensity, the darker the band.  (Adapted from Shah et al., 
2010,  Changing concepts in the characterisation of microbes and the influence of mass 
spectrometry. In: Shah H.N. and Gharbia, S.E. (eds).  ‘Mass Spectrometry for Microbial 
Proteomics’ Wiley, Chichester, pp. 3- 34]. 
 
Datasets obtained from SELDI-TOF MS analysis were complex and the accompanying 
software utilised heatmaps to visualise differences in mass ion intensities (Shah et. al., 2010). 
However, raw data could also be extracted and analysed separately. Artificial neural 
networks were generally employed to assess the diversity of species (Encheva et. al., 2005; 
Schmid et. al., 2005; Lancashire et. al. 2005, Hamilton et. al., 2010, Chiu, 2014). Large 
proteins of >150,000 daltons were reported while mass spectra were so vast that PHE 
considered this as more a comprehensive and robust method for typing bacterial species 
(Shah et. al., 2005, Encheva et. al., 2006). The launch of Ciphergen Biosystems next 
generation ProteinChip System, Series 4000 in 2004 enabled rapid biomarker discovery and 
development of predictive, high throughput SELDI-based analysis. Unfortunately, 
laboratories with the first generation MALDI -TOF MS instruments on which considerable 
background was undertaken, were left unsupported. In 2006, the company was acquired by 
Bio-Rad and there was an abrupt loss of interest for the technology in microbiology.   
 It was evident that for any of these technologies to have a future, a comprehensive 
microbial database of mass spectral profiles of species was required. Early protocols for 
analysis of whole cells by MALDI-TOF MS again resorted to the use of different matrix 
solutions based upon the Gram stain. In general, laboratories utilised alpha-cyano-4-
hydroxycinnamic acid for Gram-negative cells and 5-chloro-2-mercaptobenzothiazole for 
Gram positive cells. Having optimised a method based on available data, considerable in-
house laboratory work was undertaken to initiate this process (Shah et. al.,2000, 2002).  With 
the arrival of a dedicated new upright linear MALDI-TOF MS instrument by Micromass 
(later acquired by Waters Inc), four years was spent developing the first mass spectral 
database (Key et. al., 2004). Proof of concept was demonstrated through a direct trial at The 
Royal London Hospital, University of London’s diagnostic laboratory and was highly 
successful. More than 600 isolates were analysed in parallel with traditional tests undertaken 
in the hospital’s laboratory and yielded an 80% concordance (Rajakaruna et. al., 2009).   
During this period, infections due to Clostridium difficile in the UK was at its peak 
and MALDI-TOF MS was again used to access its potential value. Initial results were 
spurious and led to a re-examination of the basic protocol. A change from 5-chloro-2-
mercaptobenzothiazole to 2,5-dihydroxy benzoic acid in acetonitrile: ethanol: water (1:1:1) 
with 0.3 % TFA (see Shah et. al.,2010) led to a dramatic improvement in results. Similar 
results were also obtained using -cyano-4-hydroxycinnamic acid. Furthermore, re-
optimisation of protocols led to the use of a preliminary extraction with formic acid and the 
use of -cyano-4-hydroxycinnamic acid for both Gram positive and Gram-negative cells. 
This was demonstrated in several laboratories by a group who met periodically to optimise 
methods (Kallow et. al., 2010). It was soon evident that MALDI-TOF MS spectra gave 
similar results to its corresponding ribosomal RNA preparation of various species and 
provided unequivocal proof that these are the molecules that gave rise to the specific mass 
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ions that comprised the spectrum of a given species. This removed the need to standardise the 
growth conditions since the mass spectra were not adversely affected by the physiological 
conditions of the cell. A universal protocol was now established for use with all microbial 
species and interest in the technique gained momentum. Commercial databases were now 
available through Bruker Daltonik GmbH (Bremen, Germany) and AnagnosTec (Potsdam, 
Germany, subsequently acquired by bioMerieux).  
 In 2011, the UK was in the midst of preparations for staging of the London 2012 
Olympics. Part of these preparations was a responsibility by Public Health England (PHE) to 
implement technologies that enabled rapid identification of pathogens in the event of an 
infectious disease outbreak.   A proposal by the Molecular Identification Services Unit, PHE 
led to the placement of six MALDI-TOF MS instruments initially and a further 10 
instruments in major cities in the UK. It represented the largest network of instruments in one 
organisation globally and endorsement of the technology after 13 years of consolidated work. 
It continues to function to the present and retained parallel analysis using comparative 16S 
rRNA sequence analysis.   
 
10.5    MALDI-TOF MS in the non-clinical laboratory and its role is searching for new 
diversity.  
 
Because MALDI-TOF MS databases were assembled using mainly clinically relevant strains 
for species identification, it was assumed initially that application of the technology for 
identification of isolates from other sites such as the soil, marine, freshwater, agricultural, 
poultry, and industrial waste, bioremediation in landfill sites, inhospitable sites, 
manufacturing etc would require new databases with correspondingly relevant species. The 
method began attracting interest a decade ago and several specialist groups utilised an 
existing database in tandem with 16S rRNA sequencing to extended applications of the 
technology. Species that could not be detected by MALDI-TOF MS but identified by 16S 
rRNA were added to the database for studying microbial communities of hitherto poorly 
studied sites. Such an approach in which MALDI-TOF MS and 16S rRNA are used in 
parallel and the latter used to add new diversity to a pre-existing mass spectral database has 
successful moved the technology well beyond the clinical laboratory where it had its roots.  
For example, MALDI-TOF MS and the 16S rRNA were used in tandem for characterising 
the cultivable bacterial communities from polluted soils and water following copper mining. 
The results revealed that MALDI-TOF MS analysis was reliable and could be used as a rapid 
tool for identifying copper-resistant bacteria (Avanzi et.al., 2017). As anticipated some 
results were equivocal but accuracy was improved by enhancing the reference database. In a 
very interesting application, Timperio et. al., (2017) studied Arctic bacteria isolated from the 
White Sea, Russia in parallel with 16S rRNA. Agreement between both methods was 100% 
at the genus level but decreased to 48% at the species level but subsequently remedied by the 
inclusion of the missing reference spectra to the database. Notable examples were strains of 
Exiguobacterium oxidotolerans and Pseudomonas costantinii that were misidentified initially 
using the MALDI BioTyper due to the absence of reference spectra in the database. 
Interestingly, the concordance for Pseudomonas species was low (29%), confirming the 
problematic taxonomy of this genus and highlighted areas where the use of MALDI-TOF MS 
may be used in systematics.  In vastly different study, the geo-microbiology of a 300 m 
stretch of a rivulet with very hard water (>120 mg Ca2+/L) in a northern-Germany karst 
hardwater creek, the Westerhofer Bach was investigated using 16S rRNA and MALDI-TOF 
MS as a phenotypic method. Some 35 genera were identified which included a predominance 
of  Flavobacterium, Pseudomonas and Stenotrophomonas and some 60 novel phylospecies. 
The study provided deep insight into the bacterial community of the geosphere and biosphere 
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of a non-marine environment (Cousin et al., 2008) and demonstrates the versatility of the 
technique.  
Habitat selection and human transmission of P. aeruginosa is currently being 
investigated. Strains from environments across London are being sampled and analysed by 
MALDI-TOF MS following presumptive identification on agar plates. MALDI-TOF MS in 
parallel with 16S rRNA revealed that several phenotypically closely related isolates that 
produce the characteristic fluorescent and green pigments on agar may have been incorrectly 
misidentified P. aeruginosa, instead of Pseudomonas citronellolis (Louise Duncan, current 
PhD in progress, unpublished). P. citronellolis is a documented soil microbe that exhibits a 
strong biotic relationship with pine trees or basil plant host (Seubert, 1960; Remus-
Emsermann et. al., 2016). Interestingly, P. citronellolis was reported for the first time in a 
case of human infection (Williams, 2019) and demonstrates the value of MALDI-TOF MS in 
studying microbial community habitats (Duncan et. al., 2019).  Investigation into these 
microbial communities reveal that phenotypical colour formation is not an exclusive property 
of P. aeruginosa (Pirnay et. al., 2009; Batrich et. al., 2019). Therefore, MALDI-TOF MS 
proved to be a highly sensitive and accurate tool for identifying diverse species of 
Pseudomonas.  
The application of MALDI-TOF MS to bacterial identification is key to both 
diagnostic laboratories and industry. Food and beverage manufacturers are disposing of their 
traditional microbiology laboratories methods and turning toward the routine usage of 
MALDI-TOF MS through various stages of production (see egs, Pavlovic et al., 2013; 
Santos, Hildenbrand and Schug, 2016). It facilitates rapid communication of important 
quality control results thus preventing the contaminated products from leaving the 
manufacturing environment to distributors and the subsequent consumer (see Bourassa, 2018)    
These studies, together with the huge volume of reports on the successful use of 
MALDI-TOF MS in clinical laboratories indicate that where the taxonomy of species are 
unambiguous and the associated reference spectra are in the database employed, the use of 
MALDI-TOF MS for microbial species identification appears likely to be continued for the 
foreseeable future. The exception to date is Mycobacterium spp. where the rigid cell wall 
contains very complex long-chained fatty acid of up to 80 carbon atoms and additional 
extraction methods are required. Furthermore, many species are so poorly resolved that a 
separate database is generally created for this genus and lower threshold scores are used to 
identify some species (see egs, Kim and Kim, 2017, Kim et. al., 2020, Pranada et. al., 2017, 
Rose et. al.,2017). 
10.6    MALDI-TOF MS in subspecies identification, typing and screening for genetic 
variants. Implication for systematics. 
Among certain taxa where subspecies level identification is apparent and better defined, 
MALDI-TOF MS has been used to delineate such diversity. Among members of the genus 
Lactobacillus, several species and subspecies are recognised and commonly used as 
probiotics. Most species of Lactobacillus may be identified using MALDI-TOF MS and 
several subspecies for example, Lactobacillus delbrueckii subspecies delbrueckii, 
Lactobacillus delbrueckii subspecies lactis, Lactobacillus delbrueckii subspecies indicus, 
which are favoured by various probiotic companies and needs authentication and verification, 
may also be delineated by MALDI-TOF MS. Many companies such as Natren Inc, Westlake 
Village, California, USA, previously used long-chained fatty acids to detect minor strain 
variation to characterise starter cultures and ascertain strain stability during manufacturing. 
Today, this has been transformed by the use of MALDI-TOF MS for rapid and routine 
monitoring. Public Health England has worked closely with Natren Inc to assess the potential 
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of MALDI-TOF MS to identify probiotic Lactobacillus spp and Bifidobacterium spp. in 
parallel with 16S rRNA and, in some species, whole genome sequencing and found excellent 
correlation (see eg Figure 10.2). 
 [Insert Figure 10.2. The separation of Lactobacillus species and subspecies using Bruker 
Biotyper (software version 3.0). The results highlight the capacity of MALDI-TOF MS to 
delineate some taxa to the subspecies level. These include: Lactobacillus delbrueckii 
subspecies delbrueckii, Lactobacillus delbrueckii subspecies lactis and Lactobacillus 
delbrueckii subspecies indicus which are frequently used by various probiotic companies]. 
 
Numerous reports highlight the use of MALDI-MS in the detection of genetic variants and 
the typing of a vast range of species such as Staphylococcus aureus, Pseudomonas spp, 
Clostridium difficile, Bacillus spp, Listeria monocytogenes, Salmonella spp, Streptococcus 
spp, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and others (see 
Biswas, Gouriet and Rolain, 2016). We have investigated the capacity of MALDI-TOF MS 
to subtype the above taxa against a recognised DNA-based typing system and have 
consistently failed to substantiate such correlations. It is sometimes assumed that because 
MALDI-TOF MS spectra comprise mainly highly conserved ribosomal protein structures, 
dendrograms would mirror 16S rRNA trees. However, concordance between both is 
uncommon except where taxa have very high gene sequence similarities (>98.2 % ) 
(Schumann and Maier, 2014). However, we could not demonstrate this for strains of P. 
aeruginosa that were >99% similarity in 16S rRNA and bifurcations were not shared in 
dendrograms. Figure 10.3 shows an example of the discordance among isolates of 
Pseudomonas aeruginosa using MALD-TOF MS against the DNA-based typing system 
(VNTR’s) that is used routinely at Public Health England. Similarly, Schumann and Maier 
(2014) reported the dendrogram generated on the basis of MALDI-TOF MS did not 
correspond with the topology of the tree derived from their 16S rRNA gene sequences for the 
type strains of type species of genera of the family Microbacteriaceae or genus Arthrobacter. 
 
 
[Insert Figure 10.3.   Dendrograms showing phenotypic similarities and relationships of 53 
Pseudomonas aeruginosa strains from cystic fibrosis (CF) and non-CF sites and the same 
strains analyzed genetically using VNTR (variable number tandem repeat). Congruence 
between the phylotypes was negligible and indicate that one method cannot supplant another. 
(Adapted from Olkun, Shah and Shah, 2017, ‘Elucidating the intraspecies proteotypes of 
Pseudomonas aeruginosa from cystic fibrosis. In: Shah, H.N. and Gharbia, S.E. (eds). 
MALDI‐TOF and Tandem MS for Clinical Microbiology. Wiley, Chichester, UK, pp 579 – 
592]. 
 
Each method is based on different target molecules and was expected to differ as 
these results demonstrate. If the long-term goal of such studies is to use MALDI-TOF MS to 
replace a recognised DNA-based typing system, our studies have shown that this is not 
achievable. However, if the objective is to use MALDI-TOF MS exclusively to establish a 
‘mass spectral typing’ system for use within a specific laboratory, indications are that this is 
achievable. Figure 10.4 shows samples from a study to map the transmission of 
Staphylococcus aureus and related species in the community. A total of 411 isolates were 
recovered from the general public and various environmental sites in London. The MALDI-
TOF MS data was analysed using the software BioNumerics (Applied Maths; Vranckx, De 
Bruyne and Pot, 2017) and evidence of clustering within the same sites were apparent with 
the human hand being the reservoir (Xu et al., 2017;). Nineteen species of staphylococci were 
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identified, most of which were coagulase negative. BioNumerics revealed hierarchical 
interrelationships of nine major clusters comprising S. hominis, S. haemolyticus, S. 
epidermidis, S. pasteuri, S. warneri, S. aureus, S. saprophyticus, S. capitis and S. simiae 
(Figure 10.4).     
 
[Insert. Figure 10.4  (Left) Unrooted cluster analysis of staphylococcus species in the 
community based upon MALDI-TOF MS spectral profiles. While each species was 
distinctively delineated, the data enabled the intraspecies diversity to be clearly discerned (Xu 
et. al, 2017. Adapted from “Subtyping of Staphylococcus spp. based upon MALDI‐TOF MS 
data analysis. In: Shah, H.N. and Gharbia, S.E. (eds). MALDI‐TOF and Tandem MS for 
Clinical Microbiology. Wiley, Chichester, UK, pp 563 - 378. 
 
[Insert. Figure 10.4 (Right) Three-dimensional scatter plot Staphylococcus aureus isolates 
using a supervised method such as linear discriminant analysis (LDA, Bionumerics) to show 
relationships among isolates from specific sites which may be useful for identifying unique 
traits during transmission (Adapted from Vranckx, K., De Bruyne, K. and Pot, B. (2017) 
“Analysis of MALDI‐TOF MS spectra using the BioNumerics software”. In: Shah, H.N. and 
Gharbia, S.E. (eds). MALDI‐TOF and Tandem MS for Clinical Microbiology. Wiley, 
Chichester, UK, pp 539-562.] 
It is our view that with the current level of resolution of the technology, MALDI-TOF MS is 
excellent for species and in some instances subspecies-level identification but does not 
provide a means to type isolates in a manner similar to DNA-based methods. Table 10.1 
highlights some of obstacles to develop a universal typing platform analogous to the 
databased developed for species identification.  However, the value MALDI-TOF MS as a 
tool for microbial systematics has been grossly undervalued and reports in systemic journals 
remain sparse despite an early report by Schumann and Maier (2014) that provides detailed 
methods for adapting MALDI-TOF MS towards systematics applications.  
 
[Insert Table 10.1 Barriers to using MALDI-TOF MS exclusively as a universal typing 
tool] 
 
10.7     MALDI-TOF MS in microbial systematics; a case study involving Cutibacterium 
acnes. 
The widespread use of comparative 16S rRNA sequence analysis enabled the 
transition of a determinative microbial classification system to a phylogenetic structure (see 
above, 10.1). Systematic subcommittees provide essential information on the proposal of new 
species and continues to ensure that a polyphasic description is still the desired approach (see 
Chapter 2). However, several species are still proposed solely on the basis of 16S rRNA 
where a level >98.8% has been detected and where there is a paucity of reliable characters to 
facilitate its identification. While whole genome sequencing (WGS) represents the most 
comprehensive data available to describe a new taxon, acquired genetic elements may skew 
the description of the new entity. Consequently, in silico DNA-DNA hybridisation or ANI 
values are now used to circumscribe new diversity (see eg. Dekio et al.,2015). For many new 
fastidious species, especially non-fermentative taxa, characteristic phenotypic characters may 
be extremely difficult to discern. MALDI-TOF MS has the potential to provide unique 
characters. The current case report (below), based on Propionibacterium acnes, helped in its 
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reclassification to Cutibacterium acnes and provides an example of how these techniques 
may be used to reconcile microbial systematics.   
10.7.1   Brief biology of Cutibacterium acnes.                                                                                       
 C. acnes (previously, Propionibacterium acnes) is a facultative anaerobic bacterium 
and one of the most abundant resident species of the human skin, with a count of 105-106 
cells/cm2 on the facial skin (Dekio et al., 2007). Although it is considered beneficial to 
humans, it plays a fundamental role in the development of inflammatory acne, a disease that 
gave the species its specific epithet. Moreover, it also inhabits the eye, oral cavity, large 
intestine, and genito-urinary tract of humans, and causes opportunistic infections in the 
cornea, prostate cancer, surgically-treated bone, and blood-borne illnesses.                                                                                   
 Differences in cell wall composition led to subdivision of the species into types I and 
II (Johnson and Cummins 1972), and later a group with a unique filamentous morphology, 
designated type III (McDowell et al., 2008). These groups were found to be serologically 
unique and using the housekeeping genes, recA and tly to be phylogenetically distinct 
(McDowell et al. 2005, 2008). In attempt to resolve the taxonomic substructure of the group, 
in-depth analysis using genomics and proteomics against known morphological and 
biological features were undertaken in our laboratory (Dekio et al. 2015) and those of 
McDowell et al. (2016). To clarify the role of C. acnes in acne, studies have focussed on 
potential virulence determinants which finally led to the conclusion that type I was 
responsible for inflammatory acne (Lomholt & Kilian, 2010). 
10.7.2    MALDI-TOF MS delineates three proteotypes     
Finding characters that consistently discriminate bacterial strains below the species 
level is often fraught with difficulties. In an attempt to delineate these subtypes, we collected 
MALDI-TOF MS spectra of C. acnes strains of a dozen MLST types belonging to the types I, 
II, and III. As expected, the majority of peaks were common among the three types, but peaks 
at 6950-7200 m/z were found to be highly indicative of each type and may be used as 
biomarkers (Figure 10.5), (Nagy et al., 2013, Dekio et al., 2015). These biomarkers are 
clearly detected by MALDI-TOF MS and have been confirmed at four different institutes, 
Keio University, Japan, Japan Collection of Microorganisms, Japan, Public Health England, 
UK and Middlesex University, U.K. with acceptable shifts in m/z values.                                            
 [Insert Figure 10.5. Unique biomarker mass ions in the MALDI-TOF MS spectrum of 
Cutibacterium acnes subspecies (Dekio et al. 2015). 
 These results were corroborated using another form of MALDI-TOF MS, SELDI-
TOF MS which analysed a far greater depth of the proteome (see above, Sect 10.4).  
Furthermore, the more precise analysis with the wider mass range of mass ions provided by 
SELDI-TOF MS was found to be useful in functional investigations. C. acnes isolates 
showed significantly higher expression of a protein with a mass range ca.15-17kD in type I 
(Figure 10.6). This expression disappears almost completely when cells were cultured under 
aerobic conditions (Dekio et al. 2013).  
 [Insert Figure 10.6. Unique biomarker mass ions between 10-20 kD segment of the 
SELDI-TOF MS spectra of anaerobically-cultured Cutibacterium acnes isolates 
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 We further investigated this peak following preliminary separation by 1D SDS-
PAGE, protein extraction and tandem LC/MS/MS using a ThermoFisher Orbitrap. Among 
several proteins contained in this gel-band, CAMP factor, an infection-related protein, was 
identified. This protein is hypothesised to be a key protein related to development of 
inflammatory acne (Dekio et al., 2013).  
10.7.3     Correlation of proteotypes with whole genome sequencing                            
 Since the taxonomic basis of the prototypes of Cutibacterium acnes was established 
using primarily MALDI-TOF MS and its extended form, SELDI-TOF MS, a key 
consideration was to investigate the rigor of these subtypes by their correlation with genome 
sequencing. While they showed 16S rRNA gene similarity of > 99.3%, the genome similarity 
of each group, calculated by in silico DNA-DNA hybridization, were in the range 78-72%, 
slightly higher than that accepted for a species cut off of 70% (Dekio et al., 2015). This 
resulted in the confirmation of the three subspecies viz. C. acnes subspecies acnes, C. acnes 
subspecies defendens, and C. acnes subspecies elongatum, for types I, II, and III, respectively 
(Dekio et al., 2019, McDowell et al. 2016). Unlike many taxa where there is a paucity of 
reliable characters for subspecies-level identification, these results demonstrate unequivocally 
the huge potential of MALDI-TOF MS and proteomics in microbial systematics.    
 [Insert Figure 10.7. Genome phylogram for type strains of Cutibacterium species and 
subspecies that confirmed the initial data obtained by MALDI-TOF and SELDI-TOF MS 
analyses and emphasise the value of the latter techniques in preliminary screening of isolates 
from diverse habitats].  
10.8     MALDI-TOF MS and the future interest of MS companies 
10.8. 1    The current and long-term microbiological usage of MALDI-TOF MS is entirely 
dependent on the interest and development of leading MS companies. Around the globe there 
are numerous MS companies and several manufacture MALDI-TOF MS instruments, yet 
despite the success of the technology and its transformative impact in clinical microbiology, 
only two companies, Bruker Biotyper (Bruker Daltonics, Germany) and bioMérieux (in 
partnership with Shimadzu, Japan; VITEK ® MS System, France) dominated the global 
market. However, this is likely to change because more companies are showing an interest to 
enter the field. The arrival of ASTA’s MALDI-TOF MS (Tinkerbell LT, ASTA, Korea) and 
recent developments at Ascend Diagnostics Ltd, Manchester are examples. The latter’s new 
MALDI-TOF MS platform designated Lexi TM is a state of the art MALDI benchtop Mass 
Spectrometer that allows rapid identification of microorganisms. Its novel electronic and 
mechanical modules are embedded in a compact and robust design generating the smallest 
footprint on the market at present. The unique features and versatility of this instrument and 
other platforms that enable users to have more flexibility is likely to stimulate further interest 
across the breadth of microbiology.  
The most significant barrier to more MS companies entering clinical microbiology is 
the monumental task of developing an accredited microbial database for use with a new 
instrument. ASTA has successfully achieved this and demonstrated the reliability of their 
MicroIDSys system (ASTA, Korea) by carrying out parallel studies using the Bruker 
Biotyper (Bruker Daltonics, Germany) on over 5,000 clinical isolates. Identical results with 
high confidence scores (≥ 2.0 for Bruker Biotyper), and (≥140 for ASTA MicroIDSys) were 
obtained for 86.1% of isolates with 99.2% (4,267 strains) showing good scores in both 
systems. The authors concluded that the ASTA MicroIDSys had the capacity to reliably 
 12
identify clinically important microorganisms (Lee et. al., (2017). In further developments, the 
ASTA MicroIDSys was challenged with 370 clinical anaerobic isolates and attained 91.6% 
success at the species level. Among these were many poorly described species and many non-
fermentative taxa that are normally difficult to speciate (Kim et al. 2020).   
The MS companies SAI (Scientific Analysis Instruments, Manchester, UK), Waters 
Corporation, Elstree, UK (formerly, Micromass) and Shimadzu Corporation, Japan   
have been manufacturing MALDI-TOF MS instruments at the onset of these developments 
and have shown a long-term interest in promoting microbiological applications. Two other 
MS companies, AB Sciex and Thermo Fisher Scientific supplies tandem MS instruments that 
are likely to feature significantly in the future development of microbial proteomics and 
diagnostic applications in microbiology.  
   
10.8.2     The initial microbiological development and acceptance of the MALDI-TOF MS 
was mainly in Europe. A decade later when accreditation was achieved, the technology 
entered the USA market and met considerable approval by some of the leading laboratories 
(see eg Patel, 2013, Angeletti, 2017). This was subsequently mirrored in many developing 
countries largely because after the outlay for an instrument, the accuracy, robustness, low 
running cost and simplicity of the method markedly surpasses traditional methods. 
[Insert Table 10.2. Summary of the current advantages of MALDI-TOF MS]  
 
10.8.3 Limitations of MALDI-TOF MS as currently used.                                                                  
Use of mass spectral pattern matching profiles of mass ions to delineate bacterial species has 
enabled microbiologists to demonstrate unequivocal proof of concept. These biomarker mass 
ions are largely derived from the high abundant ribosomal proteins of the cell and their 
stability and reproducibility has been pivotal in the development of a universal method that 
has gained widespread appeal at the special level. Its application to the subspecies level using 
mass spectral profiles is equivocal (see above 10.6). Indications are that several of the minor 
peaks in the mass spectrum may be lipids/lipoproteins/glycolipids and may provide 
biomarkers for subspecies level identification as shown for yeast and fungi (Stübiger et. al., 
2016). These molecules have been extensively studied in bacteria using older forms of MS 
(see Minnikin and Goodfellow, 1980) but to date the use of MALDI-TOF MS to aid 
species/subspecies identification has not been demonstrated.  
DNA-based methods are inherently more precise and, an elegant method  developed 
by Hiroto Tamura, takes advantage of the exactitude of DNA and combines it with the ease 
and speed of MALDI-TOF MS (Tamura, 2017). The method expands the use of the 
ribosomal proteins used in current MALDI-TOF MS analysis but differs in that it decodes the 
base sequence for the S10-spc-alpha operon which codes for approximately half of the 
ribosomal proteins. Designated the S-10-GERMS method, it allows rigorous typing of 
bacterial isolates. Compared to conventional gene-based typing methods which requires DNA 
sequencing, Tamura’s method is simpler and rapid and has been adopted by Shimadzu 
Corporation, Japan (see Microorganism Identification System).  
 
 
10.9     Retaining the interest of Mass Spectrometry companies. 
 
While there is enormous interest by microbiologist to retain the use of MALDI-TOF 
MS for the foreseeable future, interest by the MS companies will depend on financial returns. 
Several MALDI TOF MS companies have contributed significantly to the development of  
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applications of the technology but subsequently discontinued their interest due to budgetary 
constraints or a change in the direction of the company’s strategy as noted above for 
Micromass M@LDI -MS (Waters Corporation), Sequenom MassArray system or Ciphergen 
Biosystems SELDI-TOF MS. In general MS companies need to work with microbiologists to 
assemble appropriate databases; the exception is Bruker Daltonik GmbH, who established 
their own microbiology facility at Bremen, Germany. The Shimadzu Corporation developed a 
database for use in the Far East while in Europe and America, they utilised the expanded 
accredited database of bioMerieux who drives the application of the method globally.  
Several studies have shown near congruent results through parallel analyses of the 
same samples using the Bruker Biotyper and bioMerieux VITEK MS (see eg. Lévesque,   et. 
al., 2015). Each sample needed to be run according to the methodology and analysed using 
the search engine of each platform and may have accounted for minor differences in output.  
The ASTA (MicroIDSys system, ASTA, Korea) is unique in that they are the only non-
specialist MS company to have successfully built their own MALDI-TOF MS instrument for 
microbiological applications. Their design features include a target plate that may be fitted to 
a Bruker’s Microflex LT/SH or Autoflex LRF MALDI TOF MS. The 384 well target plate 
therefore allows for the first time MALDI-TOF MS analysis of the same sample on two 
entirely different platforms. The ability to be able to combine the use of two different 
instruments and databases adds new depth and confidence to the type of analyses that may 
now be undertaken. This was demonstrated in our laboratory using several staphylococcal 
species analysed on both instruments; Bruker’s Autoflex LRF and ASTA’s Tinkerbell 
MALDI TOF MS, with considerable ease and confidence (see Figure 10.8) 
 
[Insert. Figure 10.8 (Left). MALDI-TOF MS analysis of staphylococcal species using 
ASTA’s Tinkerbell Linear MS and Bruker’s Autoflex LRF MALDI TOF MS. An example 
using Staphylococcus sciuri showing the spectrum obtained on ASTA’s Tinkerbell Linear 
MS (red) which was superimposed on the Bruker’s Autoflex LRF MALDI TOF MS spectrum 
(light blue). The results show unequivocally the correspondence of the major mass ions of 
this species.  
 
[Insert. Figure 10.8 (Right). 16S rRNA identification of 10 atypical strains of 
Staphylococcus cohnii. Both instruments revealed low identification scores, but most samples 
were correctly identified. The identification scores of seven strains were too low to provide 
an identification while strain 319 was incorrectly identified as Mycobacterium lylae using 
ASTA’s Tinkerbell MS. Once added to the ASTA database, this and other strains were 
correctly identified].   
 
 
The key to successful identification of an isolate is the comprehensive databases held 
by these companies which are continually expanding and released periodically. While 
valuable for users this remains a significant financial burden for more modest laboratories, 
particularly those in developing countries where paradoxically, more diversity may be 
encountered. Ideally, an online database of MALDI-TOF MS profiles analogous to DNA 
sequencing databases would remove the constrains currently imposed by a company-based 





10.10        Potential to identify the biomarker peaks in a MALDI-TOF MS Spectrum;          
Towards  MALDI-TOF MS global database.                                                                           
The development and clinical applications of MALDI-TOF MS began in Europe in the late 
1990s, gained confidence in the USA a decade ago and in now rapidly being implemented in 
in many developing countries. To date attempts have not been made to identify the key mass 
ions in the MALDI-TOF MS spectra that give each species its unique signature. However, as 
MALDI-TOF MS is used more for systematics it will be necessary to identify signature mass 
ions that may be added to the description of a new species as described above (Section 10.7) 
for the subspecies of Cutibacterium acnes.  Being able to identify the signature mass ions of 
species will add immensely to the development of an open access global database in the 
future and help develop the next generation of MALDI-TOF MS applications. To undertake 
such a task, it will be necessary to utilise several high-resolution forms of MS which 
MALDI-TOF MS is unable to deduce.  
10.11        High-resolution forms of MS that may be used to deduce peptide/protein 
taxon-specific signatures.         
Although available MALDI-TOF MS databases encompass mass ions within the range 500 – 
20,000 daltons, most bacterial species signature biomarkers are within the 500 -12,000 
daltons and remain uncharacterised. MALDI-TOF MS is efficient at ionising proteins in this 
mass range. However, to characterise these proteins and species-specific proteins that are 
much larger in the range 50,000-100,000 daltons they need to be isolated using techniques 
such as gel electrophoresis or high-performance liquid chromatography and subsequently 
digested with a protease before MALDI-TOF MS-MS analysis and database searching. This 
can result in a better level of taxonomic identification. Furthermore, peptides that are highly 
abundant and detected reproducibly may be identified and used as biomarkers (Fox, et. al., 
2011). Alternatively, proteins can be extracted from an organism and analysed using liquid 
chromatography with high resolution accurate mass spectrometry using either top down or 
bottom up proteomic approach (Wynne, et. al., 2010). Apart from simpler sample 
preparation, compared to the bottom-up approach, the top-down workflow provides 
additional information such as post-translational modifications and identification of 
proteoforms. With rapid improvements in ion optics and vacuum technology and 
fragmentation techniques, the upper limit for top down is towards >100kDa. Groups that 
have used bottom-up approaches for proteotyping have created their own database (Jabbour, 
et. al., 2010). Currently there are no databases for processing data from either tryptic digests 
or intact proteins. Such a database could lead not only to better identification, especially for 
closely related species, but also to identification of specific protein markers. An area where 
bottom-up workflow has been used extensively is in comparative proteomics. Studies in this 
area include comparison of protein profiles of methicillin-susceptible and resistant 
Staphylococcus aureus (Xu et. al., 2020), antibacterial mechanism of antibiotics (Ma, et.al., 
2017), resistant mechanisms (Chen, et. al., 2019) and effect of culture conditions on 
organisms such as P. aeruginosa (Duncan et. al., 2019). A bottom-up workflow has also been 
used for discovery of biomarkers that can be used for detection and identification of bacteria 
(Charretier, et. al., 2015). The application of high-resolution mass spectrometry approaches 
for identification and studying the bacterial proteome would become even more widespread if 
databases were available for both top-down and bottom-up workflows.   
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10.12        From Linear MALDI-TOF MS to Tandem LC-MS/MS; unravelling the 
proteome of microbial species and future implications for bacterial systematics.  
                                                                            
To date, MALDI-TOF MS and tandem MS/MS analyses have operated 
independently, consequently the ability to rapidly link bacterial phylogenetics with potential 
environmental function has not been explored. To bridge this gap, Clark et. al., (2018) 
designed a novel MALDI-TOF MS data acquisition and bioinformatics pipeline (IDBac) to 
integrate data from both intact protein and specialised metabolite spectra directly from 
bacterial cells grown on agar. This technique organised bacteria into highly similar 
phylogenetic groups and allowed for comparison of metabolic differences of hundreds of 
isolates in just a few hours. 
The literature detailing the proteome of bacterial species is colossal and continues to 
expand appreciably. Nearly all investigations pertain to aspects of the physiological flux of 
the cell; from the effect of environmental stimuli, antibiotic resistance to studying detailed 
insight into pathogenic mechanisms of infectious agents (see eg Chamot-Rooke et. al., 2011, 
Gault et al., 2017, Soufi and Soufi, 2016, Chilton et. al., 2014, 2017). Although protein 
profiling methods gained a strong presence in microbial systematics (see Section 10.2), 
MALDI-TOF MS which utilises protein signatures dominates taxonomic and species 
identification outputs. The capability of high-resolution tandem MS methods to identify 
novel characters and translate genomic traits into phenotype that may be used in microbial 
systematics remains poorly studied. We embarked on peptide/protein analysis to decipher 
species and subspecies markers for predicting microbial behaviour and devising identification 
markers in the late 1990s using initially MALDI and SELDI-TOF MS (see Section 10.4) and 
a few years later explored the value of LC-MS/MS for higher resolution and direct 
biomarkers sequencing (see review, Shah and Gharbia, 2017). With acquisition of the first 
generation of Thermo Fisher’s LTQ Orbitrap MS, new rapid extraction methods and 
bioinformatic approaches applicable across the microbial kingdom were established 
(Lancashire  et. al., 2005, Schmid et. al., 2005) Initially, these were confined to high risk 
pathogens that are genetically indistinguishable from non-pathogenic taxa such as separating 
Bacillus anthracis from B. cereus, Shigella dysenteriae from S. boydii, Clostridium 
botulinum from Cl. sporogenes. Similarly, Burkholderia cepacian and its relationship to 
Pseudomonas aeruginosa in the cystic lung and, Mycobacterium tuberculosis, a member of 
an almost identical complex of species and subspecies known as the TB complex that 
presents huge challenges for the clinical laboratory and systematics.  
A coherent bioinformatic pipeline incorporating comparative genome sequence and 
open reading frame prediction and translation was developed (Al-Shahib et. al., 2010, Misra 
et al., 2012, 2015, 2017). This enabled the discovery of novel peptide biomarkers 
characterising isolates of each species tested using peptide sequences purified from GelC or 
nono-LC-MS/MS. Such approaches integrating peptide discovery against comparative 
genomics (eg Karlsson et. al.,2017,  2018) have the capacity to effectively utilise bacterial 
proteomes for both species, subspecies and strain level typing.  
 
10.13.        Case Study: Use of Tandem LC-MS/MS during major disease outbreak of 
pathogenic E. coli; taxonomic implications 
 
During outbreak infections, samples received by a diagnostic laboratory often comprise a 
diverse range of isolates of the putative pathogen in which the boundaries between subspecies 
are blurred or the recognition of pathogenic/non-pathogenic strains are indiscrete due to 
exchange of genetic elements. The expression of a virulence factor/s such as toxins, which 
are nearly always protein in nature, make proteomics a powerful and sensitive tool to 
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simultaneously identify isolates and map the pathogenic factors within strains. Ideally this 
should be considered against a background of in silico analysis of the relevant genome to 
provide a sound basis to screen for genetic variants to corroborate the pathogenic potential of 
the isolate in terms of its proteome.  The E. coli 0104:H4 outbreak in the summer of 2011 in 
Europe is a poignant example of the role of modern systematics in unravelling the pathogenic 
mechanisms of a well-defined taxon and controlling the outbreak.  
 
10.13.1        Nature of the Outbreak  
On 1st May 2011, an E. coli outbreak began in Germany with a few patients presenting with 
bloody diarrhoea. Within days, the aggressiveness of the strain was realised as the outbreak 
extended to eight other European countries. With over 4000 reported cases and 50 deaths, the 
status of the outbreak was soon elevated to one of the “deadliest E. coli outbreaks”. The 
outbreak strain was positively identified on 25th May by Karch and colleagues at the 
University of Münster and the Robert Koch Institute, Germany using serotyping and PCR 
assays. Multilocus sequence typing confirmed that the outbreak was caused by a single clone, 
and that it was a rare serotype viz O104:H4. This serotype is normally associated with 
enteroaggregative E. coli (EAEC) that are known to cause persistent diarrhoea, but not 
haemorrhaging or HUS. In June, patients exhibiting symptoms of the outbreak strain arrived 
in the UK. Public Health England (then Health Protection Agency) initiated plans to 
undertake the sequencing of its first in house bacterial genome and proteome sequencing to 
aid investigation of this outbreak strain.  WGS confirmed the mosaic nature of the strain’s 
chromosome which was consistent with reports from other isolates of this outbreak. Genome 
sequence of multiple strains identified virulence factors that may account for the higher 
incidence of HUS and the unique traits of the strain. Two independent groups completed 
about 80% sequencing of the outbreak isolate’s 5.2 million base pair genome and two large 
plasmids using short-read DNA sequencers (Mellmann et. al., 2011, Editorial, 2011) which 
partly explained the strain’s pathogenicity, acquisition of new genetic elements and 
evolutionary origin (Shah and Gharbia, 2012). 
 
10.13.2        Proteomics and systematics in a high containment laboratory 
Cell culture, mechanical disruption of cells, centrifugation and sample preparations were 
carried in Class 111 facilities at PHE. Proteomic analysis was performed on five strains from 
patients with confirmed E. coli 0104 infections; three clinical isolates from patients infected 
during the “German outbreak” and two other comparator strains that were from PHE’s 
archives and  previously characterized as EAEC and EHEC respectively.  
Two parallel approaches were used to reduce complexity of the protein mixture prior 
to mass spectral analysis. Initially, lysates were separated by (SDS-PAGE), gel slices 
digested with trypsin and peptides analysed using nano-LC-MS/MS. Secondly, the entire cell 
lysate was digested directly with trypsin and injected on to two LC-MS/MS systems (Thermo 
Scientific LTQ Orbitrap and Thermo Scientific LTQ Orbitrap Velos, each with a front-end 
Ultimate 3000 Dionex nano/capillary liquid chromatography system, Thermo Fisher 
Scientific) that provided ultra-high resolution and accurate mass for differentiating closely 
related peptides.  
The recorded peptide MS/MS spectra were matched to both protein and in silico genome-
translated databases to identify sequenced proteins. The peptides were then subjected to 
further analysis using bioinformatic pipelines to characterise  unique signatures. In total, 
2,500 proteins were identified from the E. coli outbreak isolates which included 68 peptide 
signatures that were not shared by EAEC or EHEC or other Enterobacteriaceae. Species-level 
peptide signatures including those for the AggR transcription factor, haemolysin protein, Aaf 
fimbriae protein, and Iha adhesion protein were detected. Furthermore, genus characteristic 
 17
peptides were also mapped, suggesting that using proteome mining, an unknown isolate can 
be identified at genus, species and strain level from a single analysis.  
 
 
10.14.        Towards a combined MALDI-TOF MS/Tandem MS/MS Platform.                                                            
 
Over the last two decades we have employed a parallel approach to maximising the 
application of proteomics to characterise bacterial species from a vast range of environments. 
The manner in which proteomic data may be used in bacterial taxonomy was reported 
previously (Nomura, 2015, Shah, 2014). While MALDI-TOF MS has gained formidable 
recognition in microbiological laboratories, the huge potential available through in-depth 
analysis of the proteome by new advanced high-resolution MS-based technologies is grossly 
underestimated (Xu et. al., 2020). The latter may be due to the absence of a high throughout, 
low cost. microscale instrument that is comparable with a MALD-TOF MS platform which 
therefore restricts the technology largely to the confines of the research laboratory. The 
methods described above (eg. Section 10.13) utilises a bottom-up approach in which cells 
need to be efficiently disrupted, lysates prepared and trypsinised prior to LC-MS/MS. This 
introduces a higher level of technical expertise and lengthy sample preparation steps which 
perhaps has also discouraged MALDI-TOF MS users. 
 More recently, Thermo Fisher Scientific usurped the well-established LTQ Orbitrap 
MS with the Q ExactiveTM Hybrid Quadrupole- OrbitrapTM Mass Spectrometer. This 
highly advanced instrument, with the facilities to now undertake Top-down MS 
proteome analysis paves the way for a more automated, high throughput platform that is 
comparable with MALDI-TOF MS. Early work done at PHE and reported at ECCMID (Shah 
et. al., 2015) showed that even for species that are genetically very closely related such as E. 
coli and Shigella sonnei that are inseparable even using WGS, Top-down MS analysis 
revealed differential biomarkers (see Figure 10.9). The next generation of MS to supersede 
MALDI-TOF MS is likely to be an instrument such as a Q ExactiveTM Hybrid Quadrupole- 
OrbitrapTM Mass Spectrometer that can analyse the bacterial proteome using a Top-down 
approach that is as manageable as processing samples using a MALDI-TOF MS instrument 
(Gault et. al., 2017; Armengaud, 2017). However, the data derived from such analyses that 
take advantage of vast amount of data derived from the entire proteome will propel 
microbiology into a new era of systematics and biology.  
 
[Insert -Figure 10.9.   Use of Top-Down Proteomics to delineate genetically closely related 
species. In an early attempt to demonstrate the high resolution of this approach, proteins 
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